Brooklyn Immunotherapeutics Inc (NQ: BTX )

N/A UNCHANGED
Last Price Updated: 4:00 PM EDT, Oct 14, 2022 Add to My Watchlist

Other Filings

Form 8-K
Source: SEC/Edgar
July 05, 2017
Form DEFA14A
Source: SEC/Edgar
May 02, 2017
Form 8-K
Source: SEC/Edgar
April 10, 2017
Form S-3
Source: SEC/Edgar
April 05, 2017
Form 8-K
Source: SEC/Edgar
April 03, 2017
Form SC 13D/A
Source: SEC/Edgar
April 02, 2017
Form 10-K/A
Source: SEC/Edgar
March 28, 2017
Form 8-K
Source: SEC/Edgar
March 27, 2017
Form 8-K
Source: SEC/Edgar
March 15, 2017
Form 8-K
Source: SEC/Edgar
February 20, 2017
Form SC 13D/A
Source: SEC/Edgar
February 16, 2017
Form 8-K
Source: SEC/Edgar
February 14, 2017
Form 8-K
Source: SEC/Edgar
February 12, 2017
Form 424B5
Source: SEC/Edgar
February 09, 2017
Form 8-K
Source: SEC/Edgar
February 08, 2017
Form 424B5
Source: SEC/Edgar
February 08, 2017
Form SC 13D/A
Source: SEC/Edgar
January 09, 2017
Form 3/A
Source: SEC/Edgar
December 14, 2016
Form 8-K
Source: SEC/Edgar
November 02, 2016
Form 8-K
Source: SEC/Edgar
September 13, 2016
Form 8-K
Source: SEC/Edgar
August 28, 2016
Form SC 13D/A
Source: SEC/Edgar
August 28, 2016
Form 8-K
Source: SEC/Edgar
August 08, 2016
Form 8-K
Source: SEC/Edgar
July 04, 2016
Form CT ORDER
Source: SEC/Edgar
June 23, 2016
Form 424B5
Source: SEC/Edgar
June 16, 2016
Form 8-K
Source: SEC/Edgar
June 16, 2016
Form 424B5
Source: SEC/Edgar
June 14, 2016
Form 8-K
Source: SEC/Edgar
June 14, 2016
Form 8-K
Source: SEC/Edgar
June 14, 2016
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.